T. Dew et al., Influence of investigative and operative procedures on serum prostate-specific antigen concentration, ANN CLIN BI, 36, 1999, pp. 340-346
We determined the effect of cystoscopy (flexible and rigid), transrectal ul
trasonography (with and without needle biopsy of the prostate) and transure
thral resection of the prostate or bladder tumour on the serum prostate-spe
cific antigen (PSA) concentration. Samples were taken from 60 men before an
d up to 14 days following these procedures.
Flexible cystoscopy did not result in a significant increase in serum PSG c
oncentration, with a median increase of 0.1 mu g/L (P > 0.05). Small but st
atistically significant increases in serum PSA levels 1 day post-procedure
were observed following rigid cystoscopy and transrectal ultrasound without
biopsy. The median increase in serum PSA concentration following rigid cys
toscopy was 0.15 mu g/L (P = 0.04) and following transrectal ultrasound was
0.3 mu g/L (P = 0.01). In both cases the serum PSA level had normalized by
2 days post-procedure. Transurethral resection of bladder tumours resulted
in a variable rise in serum PSA, with a median increase of 2.6 mu g/L afte
r 1 day, which returned to normal over 7-14 days. Ultrasound-guided needle
biopsy of the prostate and transurethral resection of the prostate produced
significant increases in serum PSA levels, which took up to fourteen days
to return to normal. The median increase in serum PSA following needle biop
sy was 6.0 mu g/L and following transurethral resection of the prostate (TU
RP) was 13 mu g/L.
Samples for PSA measurement may safely be taken within 24-48 h of flexible
cystoscopy and transrectal ultrasonography (TRUS) providing prostatic biops
y is not carried out. For other procedures it is necessary to wait for at l
east 14 days to ensure that false positive PSA results are not obtained.